These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7360207)

  • 1. No association between oral contraceptives and malignant melanomas.
    Stevens RG; Lee JA; Moolgavkar SH
    N Engl J Med; 1980 Apr; 302(17):966. PubMed ID: 7360207
    [No Abstract]   [Full Text] [Related]  

  • 2. A case-control study of the possible association between oral contraceptives and malignant melanoma.
    Adam SA; Sheaves JK; Wright NH; Mosser G; Harris RW; Vessey MP
    Br J Cancer; 1981 Jul; 44(1):45-50. PubMed ID: 7259960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk.
    Pfahlberg A; Hassan K; Wille L; Lausen B; Gefeller O
    Public Health Rev; 1997; 25(3-4):309-15. PubMed ID: 9553446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Oral contraceptives and myocardial infarction.
    Shapiro S
    N Engl J Med; 1975 Jul; 293(4):195-6. PubMed ID: 1134533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarction of the midgut associated with oral contraceptives. Report of two cases.
    Brennan MF; Clarke AM; Macbeth WA
    N Engl J Med; 1968 Nov; 279(22):1213-4. PubMed ID: 5687397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.
    Gallagher RP; Elwood JM; Hill GB; Coldman AJ; Threlfall WJ; Spinelli JJ
    Br J Cancer; 1985 Dec; 52(6):901-7. PubMed ID: 4074642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral contraceptives on the gallbladder bile of normal women.
    Bennion LJ; Ginsberg RL; Gernick MB; Bennett PH
    N Engl J Med; 1976 Jan; 294(4):189-92. PubMed ID: 1244533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use.
    Helmrich SP; Rosenberg L; Kaufman DW; Miller DR; Schottenfeld D; Stolley PD; Shapiro S
    J Natl Cancer Inst; 1984 Mar; 72(3):617-20. PubMed ID: 6583445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral-contraceptive use and bacteriuria in a community-based study.
    Evans D; Hennekens CH; Miao L; Laughlin LW; Chapman WG; Rosner B; Taylor JO; Kass EH
    N Engl J Med; 1978 Sep; 299(10):536-7. PubMed ID: 683209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
    Stampfer MJ; Willett WC; Colditz GA; Speizer FE; Hennekens CH
    N Engl J Med; 1988 Nov; 319(20):1313-7. PubMed ID: 3185634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and cardiovascular disease.
    Ratner H
    N Engl J Med; 1982 Apr; 306(17):1052-3. PubMed ID: 7063000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dermatological complications caused by oral contraceptives].
    Deharo C; Berbis P; Privat Y
    Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the association of oral contraceptives and ovarian cancer.
    Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
    N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use and malignant melanoma.
    Bain C; Hennekens CH; Speizer FE; Rosner B; Willett W; Belanger C
    J Natl Cancer Inst; 1982 Apr; 68(4):537-9. PubMed ID: 6951070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cancer.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.